Structure |
Chemical Name |
CAS |
MF |
![Spectinomycin Impurity B](/) |
Spectinomycin Impurity B |
|
|
![8-(benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium chloride](/CAS/20180528/GIF/2143944-64-1.gif) |
8-(benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium chloride |
2143944-64-1 |
C16H21N2S+ |
![Ticagrelor Related Compound 14](/CAS/20200611/GIF/2056269-94-2.gif) |
Ticagrelor Related Compound 14 |
2056269-94-2 |
C23H28F2N6O4S |
![Cefoxitin impurity E](/CAS/20211123/GIF/2395025-32-6.gif) |
Cefoxitin impurity E |
2395025-32-6 |
C17H19N3O8S2 |
![N-((4-(3-methyl-5-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide](/CAS/20180528/GIF/477594-28-8.gif) |
N-((4-(3-methyl-5-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide |
477594-28-8 |
C19H18N2O4S |
![Moxifloxacin EP Impurity D HCl](/) |
Moxifloxacin EP Impurity D HCl |
|
|
![Moxifloxacin Impurity 30](/CAS/20200611/GIF/1395056-42-4.gif) |
Moxifloxacin Impurity 30 |
1395056-42-4 |
C21H24FN3O7 |
![Tenofovir Impurity 37](/CAS/20180808/GIF/161760-03-8.gif) |
Tenofovir Impurity 37 |
161760-03-8 |
C10H15O6PS |
![Pramipexole Impurity 30](/CAS/20210111/GIF/1802051-36-0.gif) |
Pramipexole Impurity 30 |
1802051-36-0 |
C13H24ClN3S |
![NZWJKTHFNLHUJO-NWZSJJIMSA-N](/CAS/20200611/GIF/1422954-12-8.gif) |
NZWJKTHFNLHUJO-NWZSJJIMSA-N |
1422954-12-8 |
C22H26FN3O5S |
![LAT-NET](/StructureFile/ChemBookStructure6/GIF/CB3344563.gif) |
LAT-NET |
607351-44-0 |
C25H39NO4 |
![N,N-(ethane-1,2-diyl)bis(4-methyl-N-(3-((4-methylphenyl)sulfonamido)propyl)benzenesulfonamide)](/CAS/20180528/GIF/74676-47-4.gif) |
N,N-(ethane-1,2-diyl)bis(4-methyl-N-(3-((4-methylphenyl)sulfonamido)propyl)benzenesulfonamide) |
74676-47-4 |
C36H46N4O8S4 |
![L-グルコノ-1,5-ラクトン](/CAS/GIF/52153-09-0.gif) |
L-グルコノ-1,5-ラクトン |
52153-09-0 |
C6H10O6 |
![フェノフィブリン酸1-カルボキシル-1-メチルエチルエステル](/CAS/20210111/GIF/1797121-54-0.gif) |
フェノフィブリン酸1-カルボキシル-1-メチルエチルエステル |
1797121-54-0 |
C21H21ClO6 |
![2-クロロ-4'-フルオロ[1,1'-カルボニルビスベンゼン]](/CAS/GIF/1806-23-1.gif) |
2-クロロ-4'-フルオロ[1,1'-カルボニルビスベンゼン] |
1806-23-1 |
C13H8ClFO |
![Ambrisentan Impurity E](/CAS/20180529/GIF/1312092-82-2.gif) |
Ambrisentan Impurity E |
1312092-82-2 |
C21H18N2O3 |
![N-((4-(3-methyl-5-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide](/CAS/20180528/GIF/477594-28-8.gif) |
N-((4-(3-methyl-5-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide |
477594-28-8 |
C19H18N2O4S |
![Moxifloxacin EP Impurity D HCl](/) |
Moxifloxacin EP Impurity D HCl |
|
|
![Moxifloxacin Impurity 30](/CAS/20200611/GIF/1395056-42-4.gif) |
Moxifloxacin Impurity 30 |
1395056-42-4 |
C21H24FN3O7 |
![Tenofovir Impurity 37](/CAS/20180808/GIF/161760-03-8.gif) |
Tenofovir Impurity 37 |
161760-03-8 |
C10H15O6PS |
![Pramipexole Impurity 30](/CAS/20210111/GIF/1802051-36-0.gif) |
Pramipexole Impurity 30 |
1802051-36-0 |
C13H24ClN3S |
![NZWJKTHFNLHUJO-NWZSJJIMSA-N](/CAS/20200611/GIF/1422954-12-8.gif) |
NZWJKTHFNLHUJO-NWZSJJIMSA-N |
1422954-12-8 |
C22H26FN3O5S |
![LAT-NET](/StructureFile/ChemBookStructure6/GIF/CB3344563.gif) |
LAT-NET |
607351-44-0 |
C25H39NO4 |
![N,N-(ethane-1,2-diyl)bis(4-methyl-N-(3-((4-methylphenyl)sulfonamido)propyl)benzenesulfonamide)](/CAS/20180528/GIF/74676-47-4.gif) |
N,N-(ethane-1,2-diyl)bis(4-methyl-N-(3-((4-methylphenyl)sulfonamido)propyl)benzenesulfonamide) |
74676-47-4 |
C36H46N4O8S4 |
![L-グルコノ-1,5-ラクトン](/CAS/GIF/52153-09-0.gif) |
L-グルコノ-1,5-ラクトン |
52153-09-0 |
C6H10O6 |
![フェノフィブリン酸1-カルボキシル-1-メチルエチルエステル](/CAS/20210111/GIF/1797121-54-0.gif) |
フェノフィブリン酸1-カルボキシル-1-メチルエチルエステル |
1797121-54-0 |
C21H21ClO6 |
![2-クロロ-4'-フルオロ[1,1'-カルボニルビスベンゼン]](/CAS/GIF/1806-23-1.gif) |
2-クロロ-4'-フルオロ[1,1'-カルボニルビスベンゼン] |
1806-23-1 |
C13H8ClFO |
![Ambrisentan Impurity E](/CAS/20180529/GIF/1312092-82-2.gif) |
Ambrisentan Impurity E |
1312092-82-2 |
C21H18N2O3 |
![1-(((2R,4R)-4-((Benzyloxy)methyl)-2-(2,4-difluorophenyl)tetrahydrofuran-2-yl)methyl)-1H-1,2,4-triazole](/CAS/20180601/GIF/165115-83-3.gif) |
1-(((2R,4R)-4-((Benzyloxy)methyl)-2-(2,4-difluorophenyl)tetrahydrofuran-2-yl)methyl)-1H-1,2,4-triazole |
165115-83-3 |
C21H21F2N3O2 |
![1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid](/CAS/20180629/GIF/855661-71-1.gif) |
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid |
855661-71-1 |
C21H24FN3O4 |
![Iopamidol Impurity K](/CAS/20180808/GIF/1788899-70-6.gif) |
Iopamidol Impurity K |
1788899-70-6 |
C17H23I2N3O8 |
![N-[2-(ジエチルアミノ)エチル]-2-ヒドロキシキノリン-4-カルボアミド](/CAS/20180629/GIF/87864-08-2.gif) |
N-[2-(ジエチルアミノ)エチル]-2-ヒドロキシキノリン-4-カルボアミド |
87864-08-2 |
C16H21N3O2 |
![5-(2-Fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-carboxylic acid](/CAS/20180629/GIF/1883595-37-6.gif) |
5-(2-Fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-carboxylic acid |
1883595-37-6 |
C16H11FN2O4S |
![Ritonavir EP Impurity B](/CAS/20180629/GIF/765875-58-9.gif) |
Ritonavir EP Impurity B |
765875-58-9 |
C28H36N4O4S |
![3-OXO-3-(2,4,5-TRIFLUORO-3-METHOXY-PHENYL)-PROPIONIC ACID ETHYL ESTER](/CAS/GIF/112811-68-4.gif) |
3-OXO-3-(2,4,5-TRIFLUORO-3-METHOXY-PHENYL)-PROPIONIC ACID ETHYL ESTER |
112811-68-4 |
C12H11F3O4 |
![2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-N5,N5- dimethylpyrimidine-4,5,6-triamine](/CAS/20180703/GIF/1169770-52-8.gif) |
2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-N5,N5- dimethylpyrimidine-4,5,6-triamine |
1169770-52-8 |
C19H19FN8 |
![3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one](/CAS/GIF/153139-56-1.gif) |
3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one |
153139-56-1 |
C16H20N2O |
![6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-
7,9-dihydro-8H-purin-8-one](/CAS/20200119/GIF/1361569-10-9.gif) |
6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-
7,9-dihydro-8H-purin-8-one |
1361569-10-9 |
C18H13FN8O |
![Baricitinib Impurity 5](/) |
Baricitinib Impurity 5 |
|
|
![Bendamustine Impurity 28](/) |
Bendamustine Impurity 28 |
|
|
![Bortezomib Impurity 20](/) |
Bortezomib Impurity 20 |
|
|
![Canagliflozin Impurity 27](/CAS/20210111/GIF/2265214-89-7.gif) |
Canagliflozin Impurity 27 |
2265214-89-7 |
C18H14BrFS |
![Edoxaban Impurity 23 (1S,2S,4R)](/) |
Edoxaban Impurity 23 (1S,2S,4R) |
|
|
![Edoxaban Impurity 38](/CAS/20210111/GIF/2081883-53-4.gif) |
Edoxaban Impurity 38 |
2081883-53-4 |
C14H27N3O3 |
![Ezetimibe Impurity 33](/CAS/20210111/GIF/1829558-53-3.gif) |
Ezetimibe Impurity 33 |
1829558-53-3 |
C13H10FNO |
![Imatinib Impurity 14](/) |
Imatinib Impurity 14 |
|
|
![Levofloxacin Impurity 20](/CAS/20200119/GIF/CB34631849.gif) |
Levofloxacin Impurity 20 |
|
C18H20FN3O4 |
![Pantoprazole Impurity 12](/) |
Pantoprazole Impurity 12 |
|
|
![Solifenacin Related Compound 7](/) |
Solifenacin Related Compound 7 |
|
|
![Vonoprazan Impurity 12](/) |
Vonoprazan Impurity 12 |
|
|
![Brexpiprazole Impurity K](/) |
Brexpiprazole Impurity K |
|
|
![Cefaclor Impurity 3](/) |
Cefaclor Impurity 3 |
|
|
![Milrinone Impurity 7](/CAS/20210111/GIF/2250242-59-0.gif) |
Milrinone Impurity 7 |
2250242-59-0 |
C14H13N3O |
![Silodosin Impurity 1](/) |
Silodosin Impurity 1 |
|
|
![1-(((2R,4R)-4-((Benzyloxy)methyl)-2-(2,4-difluorophenyl)tetrahydrofuran-2-yl)methyl)-1H-1,2,4-triazole](/CAS/20180601/GIF/165115-83-3.gif) |
1-(((2R,4R)-4-((Benzyloxy)methyl)-2-(2,4-difluorophenyl)tetrahydrofuran-2-yl)methyl)-1H-1,2,4-triazole |
165115-83-3 |
C21H21F2N3O2 |
![1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid](/CAS/20180629/GIF/855661-71-1.gif) |
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid |
855661-71-1 |
C21H24FN3O4 |
![Iopamidol Impurity K](/CAS/20180808/GIF/1788899-70-6.gif) |
Iopamidol Impurity K |
1788899-70-6 |
C17H23I2N3O8 |
![N-[2-(ジエチルアミノ)エチル]-2-ヒドロキシキノリン-4-カルボアミド](/CAS/20180629/GIF/87864-08-2.gif) |
N-[2-(ジエチルアミノ)エチル]-2-ヒドロキシキノリン-4-カルボアミド |
87864-08-2 |
C16H21N3O2 |
![5-(2-Fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-carboxylic acid](/CAS/20180629/GIF/1883595-37-6.gif) |
5-(2-Fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-carboxylic acid |
1883595-37-6 |
C16H11FN2O4S |
![Ritonavir EP Impurity B](/CAS/20180629/GIF/765875-58-9.gif) |
Ritonavir EP Impurity B |
765875-58-9 |
C28H36N4O4S |
![3-OXO-3-(2,4,5-TRIFLUORO-3-METHOXY-PHENYL)-PROPIONIC ACID ETHYL ESTER](/CAS/GIF/112811-68-4.gif) |
3-OXO-3-(2,4,5-TRIFLUORO-3-METHOXY-PHENYL)-PROPIONIC ACID ETHYL ESTER |
112811-68-4 |
C12H11F3O4 |
![2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-N5,N5- dimethylpyrimidine-4,5,6-triamine](/CAS/20180703/GIF/1169770-52-8.gif) |
2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-N5,N5- dimethylpyrimidine-4,5,6-triamine |
1169770-52-8 |
C19H19FN8 |
![3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one](/CAS/GIF/153139-56-1.gif) |
3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one |
153139-56-1 |
C16H20N2O |
![6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-
7,9-dihydro-8H-purin-8-one](/CAS/20200119/GIF/1361569-10-9.gif) |
6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-
7,9-dihydro-8H-purin-8-one |
1361569-10-9 |
C18H13FN8O |
![Baricitinib Impurity 5](/) |
Baricitinib Impurity 5 |
|
|
![Bendamustine Impurity 28](/) |
Bendamustine Impurity 28 |
|
|
![Bortezomib Impurity 20](/) |
Bortezomib Impurity 20 |
|
|
![Canagliflozin Impurity 27](/CAS/20210111/GIF/2265214-89-7.gif) |
Canagliflozin Impurity 27 |
2265214-89-7 |
C18H14BrFS |
![Edoxaban Impurity 23 (1S,2S,4R)](/) |
Edoxaban Impurity 23 (1S,2S,4R) |
|
|
![Edoxaban Impurity 38](/CAS/20210111/GIF/2081883-53-4.gif) |
Edoxaban Impurity 38 |
2081883-53-4 |
C14H27N3O3 |
![Ezetimibe Impurity 33](/CAS/20210111/GIF/1829558-53-3.gif) |
Ezetimibe Impurity 33 |
1829558-53-3 |
C13H10FNO |
![Imatinib Impurity 14](/) |
Imatinib Impurity 14 |
|
|
![Levofloxacin Impurity 20](/CAS/20200119/GIF/CB34631849.gif) |
Levofloxacin Impurity 20 |
|
C18H20FN3O4 |
![Pantoprazole Impurity 12](/) |
Pantoprazole Impurity 12 |
|
|
![Sulpiride Impurity 1](/) |
Sulpiride Impurity 1 |
|
|
![Tenofovir Impurity 54](/) |
Tenofovir Impurity 54 |
|
|
![Cefathiamidine Impurity 10](/) |
Cefathiamidine Impurity 10 |
|
|
![Nebivolol Impurity 3](/CAS/20210111/GIF/1029684-20-5.gif) |
Nebivolol Impurity 3 |
1029684-20-5 |
C18H20FNO2 |
![Pemetrexed](/CAS/20200611/GIF/155405-79-1.gif) |
Pemetrexed |
155405-79-1 |
C12H13BrO3 |
![ethyl 2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-
carboxylate](/CAS/20200119/GIF/2230270-05-8.gif) |
ethyl 2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-
carboxylate |
2230270-05-8 |
C18H20N2O3S |
![Cefminox Sodium Impurity 6](/) |
Cefminox Sodium Impurity 6 |
|
|
![Flurbiprofen Impurity 7](/) |
Flurbiprofen Impurity 7 |
|
|
![4-(2-メチル-4,5-ジオキソイミダゾリジン-1-イル)-2,2-ジフェニルブタンアミド](/CAS/20211123/GIF/503598-05-8.gif) |
4-(2-メチル-4,5-ジオキソイミダゾリジン-1-イル)-2,2-ジフェニルブタンアミド |
503598-05-8 |
C20H21N3O3 |
![Pregabalin Impurity E](/CAS/20211123/GIF/1239692-16-0.gif) |
Pregabalin Impurity E |
1239692-16-0 |
C11H24ClNO2 |
![Rosuvastatin Impurity 86](/) |
Rosuvastatin Impurity 86 |
|
|
![Cefathiamidine Impurity 8](/) |
Cefathiamidine Impurity 8 |
|
|
![Urapidil impurity 7](/CAS/20210305/GIF/108997-11-1.gif) |
Urapidil impurity 7 |
108997-11-1 |
C24H34N4O2 |
![methyl 3-[[4-chloro-2-(phenylamino)phenyl]methylamino]-3-oxopropanoate.](/CAS/20200119/GIF/2089061-92-5.gif) |
methyl 3-[[4-chloro-2-(phenylamino)phenyl]methylamino]-3-oxopropanoate. |
2089061-92-5 |
C17H17ClN2O3 |
![Pregabalin Impurity 15](/) |
Pregabalin Impurity 15 |
|
|
![Pregabalin Impurity 32](/) |
Pregabalin Impurity 32 |
|
|
![4-Hydroxyphthalic Acid](/CAS/20210111/GIF/501666-22-4.gif) |
4-Hydroxyphthalic Acid |
501666-22-4 |
C14H25NO6 |
![Roxithromycin Impurity K](/) |
Roxithromycin Impurity K |
|
|
![Bepotastine N-Oxide Impurity](/) |
Bepotastine N-Oxide Impurity |
|
|
![Nintedanib Impurity 25](/) |
Nintedanib Impurity 25 |
|
|
![(RS)-3-tert-butyl 4-ethyl thiazolidine-3,4-dicarboxylate](/CAS/20200119/GIF/CB34693654.gif) |
(RS)-3-tert-butyl 4-ethyl thiazolidine-3,4-dicarboxylate |
|
C11H19NO4S |
![Nicorandil Impurity 7](/) |
Nicorandil Impurity 7 |
|
|
![Ritonavir EP Impurity T](/CAS/20210111/GIF/869368-48-9.gif) |
Ritonavir EP Impurity T |
869368-48-9 |
C46H66N8O5S2 |
![4-Methoxy-a-methyl-L-phenylalanine](/CAS/20200119/GIF/65555-88-6.gif) |
4-Methoxy-a-methyl-L-phenylalanine |
65555-88-6 |
C11H15NO3 |
![Cyanocobalamin](/CAS/20211123/GIF/38218-55-2.gif) |
Cyanocobalamin |
38218-55-2 |
C63H87CoN13O15P |
![Empagliflozin Impurity 44](/) |
Empagliflozin Impurity 44 |
|
|